We are only able to display limited information for this firm. We display more complete information for all of the following firms:
DLA Piper leverages a wide network that spans several UK offices as well as presences in Europe, Southeast Asia, and the United States to act on a diverse array of transactions both on the Main Market and AIM as well as on international exchanges. The team has extensive experience guiding UK clients through dual listings, and it also frequently acts on cross-border share transactions and takeover deals. The UK team is jointly led by Martin Penn, who is well-versed in advising clients in the tech and life sciences sectors on primary and secondary offerings as well as on ECM regulatory matters, and Robert Newman, who focuses on guiding UK regional clients through ECM transactions.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'Particularly impressed by pragmatism, client focus, and humanity. I can’t think of better individuals to have to spend so much time with on complex, intensive matters.'
Abbreviated data is displayed for this firm.
Key clients
- Dechra Pharmaceuticals plc
- Aptitude Software Group plc
Abbreviated data is displayed for this firm.
Work highlights
- Advised Dechra Pharmaceuticals PLC on a recommended cash offer by Freya Bidco Limited which implies an enterprise value of £4.88bn.
- Advised Medica on a potential take-private by Moonlight Bidco in an all-cash deal worth £269m.
Abbreviated data is displayed for this firm.